Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatosis 1

Explore clinical trials studying Neurofibromatosis 1. Study availability and eligibility vary by location and protocol.

133 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatosis 1 trial results

Completed

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

NCT00076102

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Childrens National Medical Center Washington D.C., District of Columbia, United States
  • Childrens Memorial Hospital, Chicago Chicago, Illinois, United States
  • Johns Hopkins Oncology Center Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

NCT00021541

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • University of Alabama at Birmingham (M1149) Birmingham, Alabama, United States
  • Children's Hospital Los Angeles, CA (M1118) Los Angeles, California, United States
  • Children's Memorial Hospital, Chicago, IL (M1484) Chicago, Illinois, United States
  • Johns Hopkins Oncology Center (M1011) Baltimore, Maryland, United States
View Trial Details
Completed

A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1

NCT00853580

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT00634270

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • National Cancer Institute (NCI) Bethesda, Maryland, United States
View Trial Details

Related conditions